Periostin, which reflects a poor prognosis of respiratory function in idiopathic interstitial pneumonia [27,28,29,30], is expected to be helpful as a biomarker reflecting disease activity and severity in routine medical care. This evidence concerns the gene POSTN and idiopathic interstitial pneumonia.